PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
Tirzepatide is a synthetic peptide with dual agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is engineered to activate both incretin pathways, making it a valuable research compound for investigating metabolic regulation and receptor signaling. Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈. Supplied as a lyophilized powder, verified at ≥98% purity via HPLC. Tirzepatide is widely utilized in in-vitro and preclinical laboratory research involving GIP and GLP-1 receptor signaling, glucose metabolism, insulin secretion, appetite regulation, energy homeostasis, and metabolic disease pathways. For in-vitro laboratory research only. Not intended for human consumption or therapeutic use.
PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
Tirzepatide is a synthetic peptide with dual agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is engineered to activate both incretin pathways, making it a valuable research compound for investigating metabolic regulation and receptor signaling. Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈. Supplied as a lyophilized powder, verified at ≥98% purity via HPLC. Tirzepatide is widely utilized in in-vitro and preclinical laboratory research involving GIP and GLP-1 receptor signaling, glucose metabolism, insulin secretion, appetite regulation, energy homeostasis, and metabolic disease pathways. For in-vitro laboratory research only. Not intended for human consumption or therapeutic use.